IBIO

iBio, Inc.

Healthcare · Biotechnology

$204.86 sample

+0.69 (+0.34%) 1D

Market cap

$354.0B

Price as of

2026-10-04

Latest filing

8-K

Alerts

8

Price$204.86 -3.62% 3M daily closessample

223.96194.58

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 22INSInsider sell: 10% owner
Sep 14INSInsider sell: Director
Sep 08INSInsider buy: General Counsel
Sep 01INSInsider sell: 10% owner
Aug 26INSInsider buy: EVP, Operations
Aug 20INSInsider buy: Chief Executive Officer
Aug 17INSInsider sell: General Counsel
Aug 10INSInsider sell: 10% owner

Sign up to see the real IBIO record →

Company facts

SEC EDGAR registration

Name: iBio, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in IBIO

sample

Insiders: 13 insider transactions over 90 days, net selling, $889.9M
Congress: 5 members traded over 90 days
Institutions · 13F: 37 funds hold $5.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.5B +14.3% y/y

Q4 2024Q3 2026

Inventory$9.5B +12.0% y/y

Q4 2024Q3 2026

Accounts receivable$7.0B +9.0% y/y

Q4 2024Q3 2026

Total debt$18.4B +5.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $154.2B +14.1% 3M
Sample peer B: $341.3B -3.0% 3M
Sample peer C: $122.6B -7.7% 3M
Sample peer D: $329.6B +4.2% 3M
Sample peer E: $170.5B +1.4% 3M